The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Kura Oncology Inc shares valued at $9,292 were sold by Bair Teresa Brophy on May 19 ’25. At $5.96 per share, Bair Teresa Brophy sold 1,559 shares. The insider’s holdings dropped to 107,948 shares worth approximately $0.67 million following the completion of this transaction.
Also, FORD KATHLEEN sold 1,558 shares, netting a total of over 9,777 in proceeds. Following the sale of shares at $6.28 each, the insider now holds 21,367 shares.
Before that, FORD KATHLEEN had added 1,558 shares to its account. In a trade valued at $9,286, the Officer bought Kura Oncology Inc shares for $5.96 each.
As published in a research note from BTIG Research on February 06, 2025, Kura Oncology Inc [KURA] has been rated down from a Buy to a Neutral. Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in late October. As of October 14, 2024, Stifel has decreased its “Buy” rating to a “Hold” for KURA. Earlier on December 22, 2023, Mizuho initiated its rating. Their recommendation was “a Buy” for KURA stock.
Analyzing KURA Stock Performance
During the last five days, there has been a surge of approximately 4.87%. Over the course of the year, Kura Oncology Inc shares have dropped approximately -28.36%. Shares of the company reached a 52-week high of $9.16 on 02/05/25 and a 52-week low of $5.41 on 04/07/25.
Support And Resistance Levels for Kura Oncology Inc (KURA)
According to the 24-hour chart, there is a support level at 6.12, which, if violated, would cause prices to drop to 5.99. In the upper region, resistance lies at 6.35. The next price resistance is at 6.45. RSI (Relative Strength Index) is 50.62 on the 14-day chart, showing neutral technical sentiment.
